Hesitation to vaccination for COVID-19 among the Brazilian adult population

Background: This study assessed the perceptions and attitudes of the Brazilian adult population about COVID-19 vaccines, seeking to identify which factors are associated with vaccine hesitancy and lack of trust in vaccines to support individual or group strategies for welcoming and guidance. Met...

Full description

Bibliographic Details
Main Authors: Henrique Pott Junior, Eveline Tonelotto Barbosa
Format: Article
Language:English
Published: Editora Unijuí 2023-04-01
Series:Revista Contexto & Saúde
Subjects:
Online Access:https://www.revistas.unijui.edu.br/index.php/contextoesaude/article/view/12806
Description
Summary:Background: This study assessed the perceptions and attitudes of the Brazilian adult population about COVID-19 vaccines, seeking to identify which factors are associated with vaccine hesitancy and lack of trust in vaccines to support individual or group strategies for welcoming and guidance. Methods: This is a national survey using a self-report web instrument in a representative sample of the Brazilian adult population (N=1700). The survey included sociodemographic and quality of life (QoL) questions, general information on COVID-19, and a vaccine-specific questionnaire. Results: The vast majority of our sample expressed favorable opinions regarding COVID-19 vaccination, but there was also a minor fraction (2.2%) of respondents who are hesitant about COVID-19 vaccination. Most of them were males within the age range of 30 to 59 years and reported that their reasons for vaccine hesitation are mainly due to uncertainty about safety (57.9%) and efficacy (36.8%) of vaccines, followed by concern with their development, that is, the issue of timing and the adoption of a new development technology (28.9%). Further, while the impact of groups and peers on those who hesitate to vaccinate was not clear, their perception of a low risk of contracting the disease is evident. Conclusions: There is a need to develop targeted strategies to increase effective communication about the risks and benefits of COVID-19 vaccines. Uncertainty about the safety and efficacy of vaccines, the timing, and the adoption of new development techniques affect significantly the perceptions on the vaccine COVID-19 acceptance.
ISSN:1676-188X
2176-7114